Data / Drug companies / CVS Woonsocket Prescription Center, Incorporated
CVS Woonsocket Prescription Center, Incorporated: 459 products in the FDA NDC directory, labeler code 51316
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
CVS Woonsocket Prescription Center, Incorporated (labeler code 51316) lists 459 products in the FDA National Drug Code Directory, covering 188 finished drugs by generic name. By type: 459 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 22, 2026.
The request: Watch CVS Woonsocket Prescription Center, Incorporated (FDA labeler code 51316): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51316
- Products in commercial distribution
- 459
- Packages
- 625
- Finished drugs by generic name
- 188
- Prescription products
- 0
- Over the counter products
- 459
- Flagged as original packager
- 412 of 412 products that carry the flag
- Started marketing in the last 12 months
- 132
- Products with a marketing end date set
- 12
- Earliest marketing start
- April 29, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 346 | 75.4% |
| Generic drugs (ANDA) | 103 | 22.4% |
| New drug applications (NDA) | 6 | 1.3% |
| Other unapproved drugs | 3 | 0.7% |
| Unapproved homeopathic products | 1 | 0.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 459 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 42 | 9.2% |
| Solution | 40 | 8.7% |
| Liquid | 37 | 8.1% |
| Spray | 29 | 6.3% |
| Tablet, film coated | 27 | 5.9% |
| Kit | 27 | 5.9% |
| Tablet | 24 | 5.2% |
| Capsule, liquid filled | 21 | 4.6% |
| Lotion | 20 | 4.4% |
| Cream | 19 | 4.1% |
| Suspension | 16 | 3.5% |
| Tablet, extended release | 14 | 3.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| CVS Medicated Heat Patch | 51316-119 | Patch | Over the counter monograph drugs | October 22, 2026 |
| Anti diarrheal | 51316-888 | Solution | Generic drugs (ANDA) | October 13, 2026 |
| CVS Calamine Plus Roll On | 51316-420 | Lotion | Over the counter monograph drugs | September 30, 2026 |
| Magnesium Citrate | 51316-883 | Liquid | Over the counter monograph drugs | September 25, 2026 |
| Adapalene Paraben Free | 51316-219 | Gel | Generic drugs (ANDA) | September 15, 2026 |
| CVS Cortisone Liquid | 51316-754 | Liquid | Over the counter monograph drugs | September 1, 2026 |
| Cetirizine HCl | 51316-900 | Capsule | New drug applications (NDA) | August 24, 2026 |
| Daytime nighttime severe cold and flu | 51316-474 | Kit | Over the counter monograph drugs | August 20, 2026 |
| Medicated BODY | 51316-519 | Powder | Over the counter monograph drugs | August 11, 2026 |
| CVS Glycerin | 51316-925 | Suppository | Over the counter monograph drugs | August 10, 2026 |
| CVS Isopropyl Rubbing Alcohol | 51316-247 | Spray | Over the counter monograph drugs | August 7, 2026 |
| CVS Beauty Hydrating Hand Sanitizer SANDALWOOD MUSK | 51316-159 | Spray | Over the counter monograph drugs | August 7, 2026 |
| CVS Beauty Hydrating Hand Sanitizer Sea Salt and Lavender | 51316-158 | Spray | Over the counter monograph drugs | August 7, 2026 |
| Nicotine | 51316-787 | Lozenge | Generic drugs (ANDA) | August 4, 2026 |
| Acne Spot Treatment Cream | 51316-972 | Cream | Over the counter monograph drugs | August 3, 2026 |
| Acid reducer | 51316-816 | Tablet, film coated | Generic drugs (ANDA) | August 3, 2026 |
| Acne Treatment Cream | 51316-654 | Cream | Over the counter monograph drugs | August 3, 2026 |
| Daily Oral Contraceptive | 51316-585 | Tablet | New drug applications (NDA) | July 28, 2026 |
| Fresh Scent PROTECTIVE BABY | 51316-518 | Powder | Over the counter monograph drugs | July 23, 2026 |
| CVS Ultra Strength Muscle | 51316-510 | Cream | Over the counter monograph drugs | July 22, 2026 |
| Acetaminophen and Ibuprofen | 51316-955 | Tablet, film coated | Generic drugs (ANDA) | July 20, 2026 |
| Esomeprazole magnesium minis | 51316-174 | Capsule, delayed release | Generic drugs (ANDA) | July 20, 2026 |
| Nighttime severe cold and flu | 51316-477 | Solution | Over the counter monograph drugs | July 14, 2026 |
| CVS Topical Anesthetic Hemorrhoidal | 51316-250 | Ointment | Over the counter monograph drugs | July 14, 2026 |
| Complete acid reducer | 51316-407 | Tablet, chewable | Generic drugs (ANDA) | July 13, 2026 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.